N

North Texas Center for Clinical Research | Rodgers Dermatology

Research site

(Unclaimed)

Location

3880 Parkwood Blvd Suite 102, Frisco, Texas, United States of America

Site insights

Top conditions

Top treatments

Camoteskimab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

This is a Phase 2a, multicenter, randomized, double-blind, placebo-controlled study with an open-label extension to evaluate the efficacy and safety...

Enrolling

Atopic Dermatitis

Eczema Atopic Dermatitis

Drug: Placebo

Drug: Camoteskimab

Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis

The purpose of this study is to determine the efficacy and safety of a monoclonal antibody, OpSCF, in the treatment of adults with moderate to severe...

Active, not recruiting

Atopic Dermatitis

Biological: OpSCF

Biological: Placebo

Trial sponsors

A

O

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms